Postponed: SRP-9001 Update
UPDATE: Sarepta will have to postpone the community webinar scheduled for today, January 21 at 12 PM EST.
PPMD is deeply disappointed as we were hopeful to discuss current data and ask questions relevant to the Duchenne community for those who are participating in gene therapy studies and those interested in participating in future studies.
We sincerely apologize for any inconvenience caused. We are working with Sarepta to reschedule this webinar. For additional information, we at PPMD have included the link to Sarepta’s most recent JP Morgan presentation including information about SRP-9001.
We will notify you with updates as soon as they become available. Please email firstname.lastname@example.org with any additional questions.
Statement from Sarepta:
Unfortunately, Sarepta will have to postpone the Community Webinar scheduled for today. We apologize for the inconvenience this may have caused anyone who was planning to attend. Please know that this postponement is not related in any way to SRP-9001 or any other clinical development program. We look forward to continuing the conversation with the community around SRP-9001.
If there are any specific questions, please reach out to advocacy@Sarepta.com